These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11916322)

  • 1. Severe hypoglycaemia in a patient with glycogen storage disease type III induced by infectious mononucleosis.
    Kimura T; Ikeda H; Kato M; Ito A; Okubo M; Hayasaka K
    J Inherit Metab Dis; 2001 Dec; 24(8):873-4. PubMed ID: 11916322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III.
    El-Karaksy H; El-Raziky MS; Anwar G; Mogahed E
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):195-200. PubMed ID: 25153581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic hyperinsulinism reversed by dietary manipulation in glycogenosis type III.
    Lee PJ; Ferguson C; Alexander FW
    J Inherit Metab Dis; 1997 Aug; 20(4):612-3. PubMed ID: 9266406
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.
    Dagli AI; Zori RT; McCune H; Ivsic T; Maisenbacher MK; Weinstein DA
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1(0 1):S103-6. PubMed ID: 19322675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary management in glycogen storage disease type III: what is the evidence?
    Derks TG; Smit GP
    J Inherit Metab Dis; 2015 May; 38(3):545-50. PubMed ID: 25164784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic glycogen storage disorders: what have we learned in recent years?
    Burda P; Hochuli M
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet therapy in severe clinical expression of debrancher deficiency.
    Azael Meza A; Ayub M; Cantú JM; Flores J
    Arch Invest Med (Mex); 1991; 22(3-4):285-8. PubMed ID: 1844114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to ACMG Practice Guidelines and ACMG Standards and Guidelines, Genetics in Medicine, July 2010, volume 12, number 7, pages 446-463 and 464-470.
    Schaefer GB
    Genet Med; 2010 Nov; 12(11):748-9. PubMed ID: 21068577
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycogen storage disease type III in Inuit children.
    Zimakas PJ; Rodd CJ
    CMAJ; 2005 Feb; 172(3):355-8. PubMed ID: 15684118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some cases of Type III glycogen storage disease.
    Rosenfield EL; Popova IA; Chibisov IV
    Clin Chim Acta; 1976 Mar; 67(2):123-30. PubMed ID: 1061645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of glycogen storage disease type Ib presenting with prolonged neonatal hypoglycaemia and minimal metabolic abnormalities.
    Matsumoto H; Kajiwara S; Ogura Y; Asano T; Horikawa R; Nonoyama S
    Acta Paediatr; 2010 Feb; 99(2):163-4. PubMed ID: 19839959
    [No Abstract]   [Full Text] [Related]  

  • 12. [Functional state of the liver in infectious mononucleosis].
    Lahtariev S; Genev G
    Folia Med (Plovdiv); 1971; 13(1):52-9. PubMed ID: 5000163
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycogen storage diseases in Thai patients: Phramongkutklao Hospital experience.
    Kamolsilp M
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S295-301. PubMed ID: 16858972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cornstarch therapy in type III glycogen-storage disease.
    Gremse DA; Bucuvalas JC; Balistreri WF
    Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lens opacities in glycogenoses type I and III.
    Allegrini D; Autelitano A; Fogagnolo P; De Cillà S; Piozzi E; Mazza M; Paci S; Montanari C; Riva E; Rossetti L
    Can J Ophthalmol; 2015 Dec; 50(6):480-4. PubMed ID: 26651310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cornstarch therapy in a patient with type III glycogen storage disease.
    Borowitz SM; Greene HL
    J Pediatr Gastroenterol Nutr; 1987; 6(4):631-4. PubMed ID: 3480949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy.
    Olson LJ; Reeder GS; Noller KL; Edwards WD; Howell RR; Michels VV
    Am J Cardiol; 1984 Mar; 53(7):980-1. PubMed ID: 6584026
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac involvement in glycogen storage disease type III.
    Moses SW; Wanderman KL; Myroz A; Frydman M
    Eur J Pediatr; 1989 Aug; 148(8):764-6. PubMed ID: 2792130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen storage disease type III with hypoketosis.
    Clemente M; Gussinyer M; Arranz JA; Riudor E; Yeste D; Albisu M; Carrascosa A
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):833-6. PubMed ID: 21073127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
    Pagliarani S; Lucchiari S; Ulzi G; Ripolone M; Violano R; Fortunato F; Bordoni A; Corti S; Moggio M; Bresolin N; Comi GP
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3407-3417. PubMed ID: 30076962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.